AGC Biologics Capacity Update May 2024: Large Molecule Development

AGC Biologics is a global CDMO that has a scientific team with 25+ years of experience, offering pre-clinical through commercial protein biologics services. Watch this presentation from the May 2024 OPCU event to learn more about AGC Biologics’ global Biologics network, track record, capabilities, and how it can provide support for any project. Watson Neto, Director of Process Transfer, also provides a detailed look at the European site in Copenhagen, which specializes in mammalian and microbial projects, and how we balance flexibility with scale to meet the demands of clients. AGC Biologics’ Copenhagen site recently expanded to double its mammalian manufacturing capacity and is actively working with developers to fill manufacturing slots.